Look for:

Our offer for

SHL TELEMEDICINE LIMITED SPON ADS EACH REP 1 ORD


ISIN:
US78423T2006
WKN:
78423T200

2024/05/10 22:30:01
Price
4.151 USD
Difference 1.38% (0.06)

General attributes

ISINUS78423T2006
SymbolSHLT
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)62 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)3.87 USD (200)
Ask (Ask size)6.56 USD (200)
Open4.151 USD
High4.151 USD
Low4.151 USD
Close (prev. day)4.0945 USD
VWAP4.151 USD
Volume (pcs)565
Trading volume2,342.31
Number of trades18
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: SHL TELEMEDICINE LIMITED SPON ADS EACH REP 1 ORDPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/04/26 en Global Equity Ratings PDF Download
2024/04/03 en Global Equity Ratings PDF Download
2024/03/13 en Global Equity Ratings PDF Download
2024/02/22 en Global Equity Ratings PDF Download
2024/02/14 en Global Equity Ratings PDF Download


2024/05/10 22:30:01
Price
4.151 USD
Difference 1.38% (0.06)

General attributes

ISINUS78423T2006
SymbolSHLT
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)62 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)3.87 USD (200)
Ask (Ask size)6.56 USD (200)
Open4.151 USD
High4.151 USD
Low4.151 USD
Close (prev. day)4.0945 USD
VWAP4.151 USD
Volume (pcs)565
Trading volume2,342.31
Number of trades18
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-51.34%-54.39%-
Perf (abs.)-4.38-4.95-
Beta0.610.310.14
Volatility73.0562.11-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)4.395 USD (3,340)
Ø price 30 days | Ø volume 30 days (pcs.)5.293 USD (4,052)
Ø price 100 days | Ø volume 100 days (pcs.)6.468 USD (3,553)
Ø price 250 days | Ø volume 250 days (pcs.)8.478 USD (3,268)
YTD High | date8.640 USD (2024/01/02)
YTD Low | date4.060 USD (2024/05/09)
52 Weeks High | date12.750 USD (2023/06/01)
52 Weeks Low | date4.060 USD (2024/05/09)

All listings for SHL TELEMEDICINE LIMITED SPON ADS EACH REP 1 ORD

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Nasdaq2024/05/1022:304.151 USD0.0018

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=11591&ID_TYPE_IMAGE_LOGO=2

Contact Details

SHL TELEMEDICINE LTD.
- -
Ashdar Building, 90 Yigal Alon Street - 67891 Tel Aviv
Telefon: +972-3-561-2212
Fax: +972-3-624-2414
E-mail: shl@shl-telemedicine.com

PDF Downloads

Company report: SHL TELEMEDICINE LIMITED SPON ADS EACH REP 1 ORDPDF Download

Company Profile

SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.

Members of Management Board

Erez NachtomyChairman of Managing Board
Amir HaiMember of Executive Committee

Board of directors

Yariv AlroyChairman of Supervisory Board
Amir LermanMember of Supervisory Board
Dvora KimhiMember of Supervisory Board
Ido NoubergerMember of Supervisory Board
Nir RotenbergMember of Supervisory Board
Yehoshua AbramowitzMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer